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Summary The neuronal ceroid lipofuscinoses (NCLs)
are inherited neurodegenerative diseases characterized
by massive accumulation of autofluorescent storage
bodies in neurons and other cells. A late-onset form of
NCL occurs in Tibetan terrier dogs. Gel electropho-
retic analyses of isolated storage body proteins from
brains of affected dogs indicated that a protein of
approximately 50 kDa was consistently prominent and
a 16 kDa component was present in some brain storage
body preparations. Mass spectral analysis identified
the 50 kDa protein as glial fibrillary acidic protein
(GFAP), isoform 2. GFAP identification was sup-
ported by immunoblot and immunohistochemical
analyses. Histone H4 was the major protein in the
16 kDa component. Specific accumulation of GFAP
and histone H4 in storage bodies has not been
previously reported for any of the NCLs. Tibetan
terrier NCL may be the canine correlate of one of the
human adult-onset NCLs for which the genetic bases
and storage body compositions have not yet been
determined.
Abbreviations
GFAP glial fibrillary acidic protein
MS mass spectrometry
MS/MS tandem mass spectrometry
NCL neuronal ceroid lipofuscinosis
Introduction
The neuronal ceroid lipofuscinoses (NCLs) are
inherited neurodegenerative disorders characterized
by massive accumulations of autofluorescent storage
material in neurons and other cell types (Haltia 2006;
Jolly 1995; Katz et al 1997; Seehafer and Pearce 2006;
Wisniewski et al 2001). A distinctive feature of the
NCLs is that the stored material contains predomi-
nantly a single protein or relatively few specific
proteins (Haltia 2006; Palmer et al 1986, 1989, 1990,
1997; Tyynela et al 1993, 1997a). There are a number
of different forms of human NCL that each result from
mutations in one of at least eight different genes
(PPT1, CLN2, CLN3, CLN5, CLN6, CLN8, CTSD
and MFSD8) (Siintola et al 2006, 2007; Steinfeld et al
2006; Wisniewski et al 2001). In the majority of these
diseases, the major stored proteins are F0 subunit c
of mitochondrial ATP synthase, a 7.6 kDa hydropho-
bic protein (Buzy et al 1996; Hall et al 1991; Kominami
et al 1992; Tyynela et al 1997b) and/or the 16 kDa V0
subunit c of vacuolar ATPase (Palmer et al 1997). In
other forms of the disease, saposins A and D are
prominent proteins in the storage bodies (Tyynela
et al 1993; Tyynela et al 1997a). Naturally occurring
NCLs have been reported in a number of nonhuman
species, including mice, sheep, cattle and numerous
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dog breeds (Awano et al 2006a, b; Jolly and Palmer
1995; Jolly et al 1992, 1994; Katz et al 2001). In cases
where the underlying mutation occurs in a gene
orthologous to one of the human NCL genes, the
major stored proteins have been found to be the same
as in the corresponding human disorders. For example,
NCL in English setters results from a mutation in the
canine CLN8 gene, and the storage bodies contain
large amounts of mitochondrial F0 ATP synthase
subunit c (Katz et al 1994, 2005a) as they do in the
corresponding human disorder (Herva et al 2000;
Ranta et al 2001).
Despite extensive research, there remain some cases
of human NCL for which the genetic basis is unknown
and in which the composition of the storage material
has not been characterized. Among these are late-
onset forms of NCL, including most cases that have
been designated as Kufs disease (Martin 1991). An
autosomal recessively inherited late-onset NCL has
also been reported in Tibetan terrier dogs (Katz et al
2005b; Riis et al 1992). The genetic basis of the
Tibetan terrier disease remains to be identified. To
determine whether the NCL Tibetan terrier storage
material is similar in protein composition to that of
other known NCLs, storage material was isolated from
brains of affected dogs and analysed.
Materials and methods
Animals and tissues
NCL in Tibetan terriers has been extensively charac-
terized in our laboratories by analysis of behavioural
signs and examination of brain and retinal tissues for
accumulation of disease-specific storage bodies (Katz
et al 2002, 2005b). Behavioural changes typically first
become apparent at 5–7 years of age and progress until
the dogs are euthanized, usually by age 10 years.
Among the behavioural signs of affected dogs are the
development of a nervous demeanour, increased
aggressiveness, loss of training, hypersensitivity to
various stimuli, loss of coordination, apparent visual
impairment, tremors and seizures. Dogs with neuro-
logical signs were identified with the assistance of the
Tibetan Terrier Club of America. We obtained health-
survey information, including the evaluation of 29
potential behavioural signs of NCL, the age of onset
for these signs, and other health and pedigree infor-
mation on the dogs. Dogs identified by these surveys
as exhibiting at least five of the primary behavioural
signs of the disease with an age of onset greater than
5 years were designated as potentially affected. The
owners of these dogs were notified and asked to
donate tissues from the dogs at the time of death.
Using this approach, brain and retinal tissues were
obtained from the Tibetan terriers used in this study.
The dogs were euthanized owing to the advanced
stage of the disease. As soon as possible after death,
the eyes and brain were collected from each dog,
usually by a local veterinarian. One eye was placed in
fixative (3.5% formaldehyde, 0.1% glutaraldehyde,
0.13 mol/L Na-cacodylate, 0.13 mmol/L CaCl2, pH
7.4) and most of the cornea was removed. Small slices
of cerebral cortex and cerebellum were placed in the
same fixative, and the remainder of the brain was
frozen. The other eye and portions of the same brain
tissues were fixed for electron-microscopic examina-
tion (Katz et al 2005b). The preserved samples were
shipped for next-day delivery to the laboratory. The
fixed tissues were processed and examined using
fluorescence microscopy and electron microscopy to
determine whether there was storage body accumula-
tion typical of this disease (Katz et al 2005b). Dogs
that showed the typical pattern of behavioural signs
with an age of onset greater than 5 years and that
exhibited the characteristic pattern of storage body
accumulation in retina, cerebral cortex and cerebellum
were designated as being affected with NCL.
Storage body isolation
In the brain, the storage material accumulation was
pronounced throughout the cerebral cortex (Fig. 1).
Cortical grey matter was therefore used for storage body
isolation. Approximately 1 g portions of cortical grey
matter were dissected from the frozen brains of three
affected Tibetan terriers that were not closely related.
The samples were each weighed and homogenized in
1 mmol/L HEPES, 5 mmol/L NaCl, 0.1 mmol/L
Na2EDTA, pH 7.2 at a concentration of approximately
1 g of tissue per 10 ml homogenization buffer. Each
homogenate was then subjected to centrifugation at
1000 rpm in a Sorvall HB-4 rotor at 4-C for 3 min. The
supernatant was collected and diluted to approximately
13 ml and then centrifuged at 10 000 rpm with the Sorvall
HB-4 rotor at 4-C for 10 min. The resultant pellet was
suspended with sonication in 12 ml of homogenization
buffer and the sample was centrifuged at 5000 rpm with
the Sorvall HB-4 rotor at 4-C for 10 min. This produced a
2-part pellet consisting of a top white portion and a
bottom yellow portion. The yellow portion of the pellet
was suspended in 4 ml of homogenization buffer and the
suspension was layered on top of 10 ml of 1.35 mol/L
CsCl in homogenization buffer in a centrifuge tube. The
sample was then centrifuged at 9500 rpm in the Sorvall
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HB-4 rotor for 40 min. The resultant pellet was washed
with homogenization buffer and portions of the pellet
were then examined with fluorescence and electron
microscopy and were used for protein characterizations.
A small fraction of each storage body preparation
(less than 5 ml) was applied to a glass microscope slide,
covered with a coverslip, and examined with fluores-
cence microscopy under conditions optimized for
visualization of storage body autofluorescence (Katz
et al 2005b). Another portion of the isolated storage
material was processed for electron-microscopic exam-
ination (Katz et al 1995). The remainder of the sample
was used for protein characterization.
Protein characterization
Isolated storage bodies were solubilized in 2% SDS
(Katz et al 1994) and subjected to SDS-PAGE using a
Criterion Precast Gel System with Tris-HCl 10–20%
gradient and 18% gels (Bio-Rad, Hercules, CA, USA).
In addition to the storage bodies from Tibetan terrier
brains, storage bodies from the brain and pancreas of
sheep with NCL were also analysed with SDS-PAGE.
The NCL sheep storage bodies were a gift from David
Palmer of Lincoln University in New Zealand (Palmer
et al 1986). Protein bands were visualized with
Coomassie blue or silver stain. Previous studies
indicated that some protein components of NCL
storage bodies do not stain with Coomassie blue, and
special silver staining techniques are required to reveal
these proteins (Fearnley et al 1990). Initial silver
staining of SDS-PAGE gels of the storage bodies using
established protocols failed to reveal the presence of a
band corresponding to vacuolar ATPase subunit c that
was previously reported to be associated with liver
storage bodies from Tibetan terriers with NCL and
pancreas storage bodies from sheep with NCL (Palmer
et al 1997). However, after experimenting with a
number of silver staining techniques an approach was
developed that did reveal additional proteins in some
samples, including a band with the same apparent
molecular weight (16 kDa) as vacuolar ATPase
subunit c. After electrophoresis, gels to be silved-
stained were fixed in 50% acetone, 1% acetic acid,
0.02% paraformaldehyde for 10 min. The gels were
then washed with water followed by incubation in 50%
acetone for 15 min. This was followed by washing in
water and then incubation in 1 mmol/L sodium
thiosulfate for 10 min. The gels were again washed
with water and then incubated in 5 mmol/L silver
nitrate, 1% paraformaldehyde for 10 min in the dark.
After washing the gels again in water, they were
incubated in developer (500 mmol/L sodium carbon-
ate, 1 mmol/L sodium thiosulfate, 0.05% paraformal-
dehyde) until protein bands appeared. Acetic acid was
added to stop the development and the gels were then
washed in 5% acetic acid followed by water washes.
After these procedures most protein bands were
visible but there was usually relatively high back-
ground staining of the gel. To specifically reduce the
background, the gels were again incubated in 1 mmol/L
sodium thiosulfate for 5 min., washed with water,
incubated in the silver nitrate solution for 10 min.,
washed with water, incubated in 5% acetic acid, and
washed again. The background reduction procedure
was repeated until proper contrast between the protein
bands and the background was achieved. As positive
controls, extracts from NCL sheep brain and pancreas
storage bodies were analysed on the same gel.
A major band of approximately 50 kDa that was
consistently seen in the Tibetan terrier storage body
extracts was excised from a Coomassie blue-stained
gel. In addition, a prominent band of approximately
Fig. 1 Fluorescence micrographs of (A) storage bodies in
cerebral cortex in situ and (B) isolated storage bodies. Bar in
(A) indicates magnification for both micrographs
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16 kDa that was present in some Tibetan terrier
storage body extracts was excised from a silver-stained
gel. The samples were destained, reduced with dithio-
threitol, alkylated with iodoacetamide and digested
overnight with trypsin. The digests were lyophilized to
dryness, reconstituted in 0.9% formic acid, and
desalted on a micro C18 Ziptip (Millipore Corp.,
Bedford, MA, USA). The digests were then analysed in
alpha-cyano-4-hydroxycinnamic acid matrix with
MALDI TOF/TOF mass spectrometry using an Applied
Biosystems (Foster City, CA, USA) model 4700 instru-
ment with a 355 nm Nd:YAG laser (200 Hz) in the
positive-ion mode. For the 50 kDa protein, the eight most
intense precursor ions were automatically selected for
tandem MS/MS analysis. Spectra were processed and
batch-analysed in the FCombined MS plus tandem MS_
mode with Applied Biosystems GPS Explorer software
(version 3.6). The mass spectral data of ions with a signal/
noise ratio >20 in the 700–4000 Da mass range (excluding
trypsin autolysis peptides) and tandem MS ions with a
signal/noise ratio >10 in the mass range from 60 Da up to
the precursor mass were matched against the NCBInr
mammalian protein database (June 18, 2006 update)
using the MASCOT search engine from Matrix Science
(www.matrixscience.com). Similar analyses were per-
formed on the 16 kDa bands from the storage body
preparations from NCL Tibetan terrier and sheep.
For the 50 kDa band, the results of the MS analysis
were confirmed by western blotting in which a portion
of the isolated storage bodies was fractionated by SDS-
PAGE as described above and transferred to a
Millipore Immobilon-P PVDF membrane (Millipore
Corp.). The membrane was probed with a rabbit anti-
human glial fibrillary acidic protein (GFAP) antibody
(AB5804, Chemicon, Temecula, CA, USA) at a 1:1000
dilution, and the bound antibody was visualized using
Chemicon BCIP/TNBT substrate (cat, no. E5007) in
conjunction with an alkaline-phosphatase-conjugated
goat anti-rabbit IgG secondary antibody (cat no.
AP307A, Chemicon) at a 1:1000 dilution.
Immunohistochemical analysis was performed to
confirm the localization of GFAP to the storage
bodies. Small slices of cerebral cortex were collected
from affected dogs immediately after euthanasia and
placed in 3.5% formaldehyde, 0.1% glutaraldehyde,
0.13 mo/L Na-cacodylate, 0.13 mmol/L CaCl2, pH 7.4.
After incubation in the latter fixative for 1 h at room
temperature, the samples were washed with 0.17 mol/L
sodium cacodylate, pH 7.4 and embedded in Tissue-
Tek freezing medium. The embedded samples were
frozen on dry ice and sections of the frozen tissue were
cut at a thickness of 5 mm with a cryostat. Sections
were mounted on Superfrost/Plus slides (Fisher Scientific,
Waltham, MA, USA) and allowed to dry overnight. The
sections were then incubated in phosphate-buffered
saline (PBS: 137 mmol/L NaCl, 2.7 mmol/L KCl,
10 mmol/L Na2HPO4, 1 mmol/L KH2PO4, pH 7.4) for
15 min, followed by incubation in blocking solution
(0.5% bovine serum albumin, 0.2% Tween 20, 0.1%
sodium azide, 5% normal goat serum in PBS) for 1.5 h.
The sections were then incubated at 4-C overnight with
the same anti-GFAP antibody used for the immunoblot
analysis diluted 1:800 in the blocking solution. Following
incubation with the primary antibody, the sections were
washed with PBS and then incubated for 3 h at room
temperature in AlexaFluor 568-conjugated goat anti-
rabbit IgG (Invitrogen A11036) diluted 1:200 in blocking
solution. The sections were then washed with PBS and
dried, and coverslips were mounted over the sections
with Gel Mount (Biomedia, Foster City, CA, USA).
Control sections of the same samples were treated
identically except that the primary antibody was left
out of the overnight incubation, which was done with
blocking solution alone. Sections were examined and
photographed using a Zeiss Axiophot fluorescence
microscope using filter sets optimized for storage
body and immunofluorescence as described previously
(Narfstro¨m et al 2003). Autofluorescence and immuno-
fluorescence images of the same areas of tissue were
merged using the DP Manager program (Olympus
Optical Co., Tokyo, Japan).
Results
Fluorescence and electron microscopy revealed mas-
sive accumulations of storage material throughout the
cerebral cortexes of Tibetan terriers that were euthan-
ized after exhibiting symptoms of NCL (Figs. 1A and
2A). The ultrastructure of the storage body contents
was somewhat heterogeneous, but most of the storage
bodies contained structures that had the appearance of
stacks of membranes in whorls or parallel arrays
(Figs. 2 and 3). Also present within the storage bodies
were coarsely granular and lipid-like components
(Fig. 3). Isolation procedures similar to those used for
other NCLs generated almost pure preparations of
these storage bodies from cerebral cortex grey matter
homogenates (Figs. 1B and 2B).
SDS-PAGE analysis of solubilized storage bodies
with gels stained with Coomassie blue revealed a single
major protein band of slightly over 50 kDa that was
present in all preparations from NCL Tibetan terrier
brain (Fig. 4A). In addition to the 50 kDA band, in
some samples silver staining revealed a strongly-
stained band at approximately 16 kDA as well as
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several bands of over 200 kDa (Fig. 4B). Only the
50 kDa band was detected in all storage body
preparations from Tibetan terrier brains. Analysis of
purified storage bodies from NCL sheep brain and
pancreas on the same gel revealed four bands with
approximate apparent molecular weights of 8, 16, 18
and 22 kDa (Fig. 4B). The 50 kDa and high-molecular-
weight bands were not observed in the extracts from
NCL sheep brain or pancreas storage bodies.
Because the 16 kDa component in some of the
Tibetan terrier storage body preparations co-migrated
with a component from the sheep storage bodies, mass
spectral analyses were performed to compare these
16 kDa bands. The mass spectral analyses of peptide
fragments from the sheep pancreas 16 kDa gel band
identified the most abundant component of this band as
histone H4 (giª57098917). Seven peptides in the tryptic
digest of the sheep pancreas band had masses that
matched those predicted for histone H4; moreover,
tandem MS analysis of two of these peptides indicated
amino acid sequences of VFLENVIR (ion score of 45;
score >43 indicated 95% confidence) and ISGLI
YEETR (ion score of 71) which matched peptides
predicted for histone H4. Mass spectral analysis indi-
cated that subunit c of mitochondrial F0 ATP synthase
was also present in this band as a minor component.
Three peptides had masses that matched those pre-
dicted for mitochondrial F0 ATP synthase subunit c;
furthermore, tandem MS identified one of these
peptides as FIGAGAATVGVAGSGAGIGTVFGSL
IIGYAR (with an ion score of 117). Western blot
analysis of the sheep pancreas storage bodies by
Palmer and colleagues had previously shown that a
gel band that they reported as having an apparent
molecular weight of 12 kDa bound antibodies from a
Fig. 3 High-magnification electron micrographs of storage
bodies in the cerebral cortex of a Tibetan terrier with NCL.
The storage body contents were heterogeneous in appearance,
consisting of membrane-like (M), course granular (G), and lipid-
like (L) components. Often all three types of material were
present within the same storage body. Bar in (B) indicates the
magnification of both micrographs
Fig. 2 Electron micrographs of (A) storage bodies in cerebral
cortex in situ and (B) isolated storage bodies. (A) A cerebral
cortical neuron, the perinuclear region of which is filled with
electron-dense storage bodies. (B) Storage body material
isolated from the cerebral cortex of a Tibetan terrier with NCL
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vacuolar V0 ATPase subunit c antiserum (Palmer et al
1997). Since no 12 kDa band was observed in our silver-
stained gels of the same storage body preparations, and
since vacuolar V0 ATPase subunit c has a molecular
weight of 16 kDa, it is likely that the band that ran at
16 kDa in our gel electrophoretic analyses corresponds
to the band reported as 12 kDa by Palmer and
colleagues. Although mass spectral analysis of this band
produced no confident identification of vacuolar V0
ATPase subunit c in the sheep pancreas storage bodies,
one lower-abundance peptide mass did match this
protein. However, the identity of this peptide could not
be confirmed by tandem MS owing to its low abundance.
Likewise, mass spectral analyses of the 16 kDa
bands from the sheep and Tibetan terrier brain storage
bodies failed to identify vacuolar V0 ATPase subunit c.
Mass spectral analysis of the 16 kDa band from the
Tibetan terrier brain preparations identified histone
H4 (giª57098917) as the major component; the masses
of four peptides from this band matched those
predicted for histone H4 with 48% coverage of the
protein. The peptides ISGLIYEETR (ion score of 56)
and VFLENVIR (ion score of 41) were identified by
tandem MS analysis of the tryptic digest from the
Tibetan terrier brain storage body sample. Haemoglo-
bin beta was also detected by MS analysis of the tryptic
digest of the 16 kDa band from the Tibetan terrier
brain storage bodies; nine peptides in the digest had
masses predicted for peptides from haemoglobin beta
(giª57113367) covering 68% of the protein and of
these three were identified as EFTPQVQAAYQK
(ion score of 52), VNVDEVGGEALGR (ion score of
61), and FFDSFGDLSTPDAVMSNAK (ion score of
104) by tandem MS analysis. The sheep brain storage
bodies also had a band with an apparent molecular
weight of 16 kDa (Fig. 4B). Mass spectral analysis of
the tryptic digest of the 16 kDa band from the sheep
brain storage bodies indicated that the most abundant
protein in this band was ubiquitin (giª51701909). Five
peptides had masses that matched those predicted for
ubiquitin and one of these peptides was identified as
IQDKEGIPPDQQR (ion score of 77) by tandem MS
analysis. MS analysis also indicated the presence of
prosaposin as a minor component of the sheep brain
16 kDa band. Tandem MS analysis indicated the
presence of the peptide GCSFLPDQYR (ion score of
47) in this band. No peptides with masses corresponding
to those predicted for vacuolar V0 ATPase subunit c
were detected in the storage body preparations from
NCL sheep or Tibetan terrier brains.
Mass spectral analysis of the 50 kDa gel band
identified it as canine predicted protein GFAP isoform
2 (giª73965502) with a MASCOT protein score of 997
(a MASCOT protein score >78 indicated a match at
the 95% confidence level). A total of 39 peptides were
matched to GFAP and these matched peptides
Fig. 4 In Coomassie blue-stained gels, a single 50 kDa protein is
the predominant component of storage bodies isolated from the
cerebral cortex of a Tibetan terrier with NCL (A, lane 1).
Immunoblot analysis of the storage body extracts using rabbit
anti-human GFAP antibody identified the 50 kDa band as GFAP
(A, lane 2). Silver staining of gels using a special protocol revealed
an additional major band at approximately 16 kDa in storage body
extracts (B, lane 1). Extracts of storage bodies from NCL sheep
brain (B, lane 2) and pancreas (B, lane 3) revealed previously
identified bands at approximately 8 kDa (mitochondrial ATP
synthase subunit c) and 16 kDa (vacuolar ATPase subunit c), as
well as additional bands at approximately 18 and 21 kDa
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covered 76% of the protein (Fig. 5A, red type). The
eight most abundant peptides in the MS spectrum
(Fig. 5B) were subjected to tandem MS fragmentation.
All of these peptides were matched to GFAP with
MASCOT ion scores ranging from 58 to 130 (a
MASCOT ion score >42 indicated a match at the
95% confidence level). The amino acid sequences of
the fragmented and matched peptides are shown in
Fig. 5C and the pertinent peaks are indicated on the
MS spectrum. These tandem MS peptides alone
covered 24% of the protein. Although peptide masses
corresponding to the conserved regions of both iso-
forms 1 and 2 of canine GFAP were matched, the
presence of the TVEMRDGEVIK peptide suggests
that the protein present in the gel band is isoform 2.
This peptide is from the variable C-terminal region of
GFAP and it is only present in isoform 2. The identity
of the storage body protein was confirmed by immu-
noblot analysis (Fig. 4B) and by immunohistochemis-
try (Fig. 6). Very few of the aggregates of storage
material in the tissue sections were associated with
cells exhibiting typical astrocyte morphology (Fig. 6).
When examined with the microscope filters used for
immunofluorescence, sections of cerebral cortex from
affected dogs that were either not immunostained or
were carried through the immunostaining procedure
with the primary antibody omitted were barely detect-
able. The storage body autofluorescence may have
made a minor contribution to the intensity of the
storage body-associated fluorescence observed when
using the microscope filter set optimized for visualizing
red-emitting fluorophores, but it was not sufficient to
interfere with GFAP immunolocalization.
Discussion
Although human and animal NCLs result from muta-
tions in more than eight different genes, they are all
characterized by massive accumulations of autofluor-
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Fig. 5 Mass spectral analysis of the
50 kDa protein isolated from the storage
bodies. (A) The amino acid sequence
of the protein identified by mass
spectrometry. The top hit from a search
of NCBInr limited to mammals was
a predicted canine protein
corresponding to glial fibrillary acidic
protein, isoform 2 (giª73965502). The
red type indicates the sequence
coverage by the 39 peptides observed in
the MS spectrum of the trypsin digest.
Peptide sequence was determined by
mass matches (peptide mass
fingerprinting) and/or by peptide
fragmentation matches (amino acid
sequencing). The underlined portion of
the sequence indicates where isoforms 1
and 2 of canine GFAP differ. (B) Mass
spectrum of peptides from the
trypsin-digested protein band. For
clarity, only those peptides masses
selected for MS/MS fragmentation are
indicated. The eight most abundant
peptide ions were automatically selected
for MS/MS fragmentation based on their
relative intensities in the MS spectrum.
(C) Table of MS/MS fragmentation
matches showing mass of the precursor
ion (peptide selected for MS/MS), the
peptide sequence, the position of the
matched peptide in the protein
sequence, the MASCOT ion score, and
the mass error associated with each
peptide sequence. The low parts per
million (ppm={[observed massj
theoretical mass]/theoretical mass}106)
mass error indicates an almost exact
match with the theoretical sequence
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escent lysosomal storage bodies throughout the ner-
vous system (Jolly 1995; Katz et al 1997; Wisniewski
et al 2001). In all types of NCL that have been
characterized to date, the storage bodies have been
reported to contain predominantly a single protein or a
few major proteins: F0 subunit c of mitochondrial ATP
synthase, vacuolar V0 ATPase subunit c, or saposins A
and D (Palmer et al 1986, 1989, 1990, 1997; Tyynela
et al 1993, 1997a). Additional proteins are variably
associated with the isolated storage bodies, but these
have not been well characterized. For example, Hall
and colleagues analysed the protein compositions of
storage bodies isolated from brains of human subjects
with various forms of NCL and the silver-stained gels
from their study contain a number of proteins with
apparent molecular weights greater than 25 kDa that
were not identified (Hall et al 1991).
The ultrastructural features of the storage bodies
are somewhat distinct between the various forms of
NCL. However, there is ultrastructural heterogeneity
in the storage bodies within most particular forms of
the disease and even between different tissues and cell
types of the same individual (Koppang 1973; Neville
et al 1980). Ultrastructural differences between the
different forms of NCL have not been correlated with
storage body protein composition (Goebel 1996, 2000;
Goebel and Wisniewski 2004; Goebel et al 1979, 1982;
Haltia 2003; Katz et al 1994; Nijssen et al 2003; Palmer
et al 1997; Wisniewski et al 2001). The storage bodies
in the Tibetan terrier cerebral cortex have components
that are somewhat similar in ultrastructure to the
Ffingerprint_ inclusions that accumulate in some of
the NCLs. However, the predominant storage body
proteins seen in other forms of NCL were not detected
in the Tibetan terrier storage body preparations. On
the other hand, the specific association of GFAP and
histone H4 with the Tibetan terrier storage bodies has
not been reported previously in other forms of NCL.
Based on SDS-PAGE analyses, a number of uniden-
tified proteins, in addition to those that have been well
characterized, are present in storage bodies isolated
from tissues of animals and humans with NCL
(Fearnley et al 1990; Hall et al 1991; Palmer et al
1986, 1997). These proteins vary in size depending on
the form of the disease with which the storage bodies
were associated and the tissues from which they were
isolated. These differences in protein composition
could account, at least in part, for the ultrastructural
heterogeneity of the storage material in the NCLs.
Differences in protein composition between different
Tibetan terrier storage body preparations may reflect
differences in the disease stage at which the dogs were
euthanized. The dogs were all privately owned and
different owners had their dogs euthanized at different
stages of the disease. The absence of the 16 kDa band
in some of the Tibetan terrier brain storage body
Fig. 6 Immunohistochemical analysis of cerebral cortex from a
Tibetan terrier with NCL. Cryostat sections of fixed tissue were
probed with an anti-GFAP antibody that was localized by a red-
emitting fluorophore bound to a secondary antibody. (A)
Fluorescence micrograph of the tissue using light filters opti-
mized for demonstration of storage body autofluorescence
(yellow). (B) Fluorescence micrograph of the same area of
tissue using light filters optimized for visualization of the GFAP
immunofluorescence. (C) An image generated by merging
micrographs (A) and (B) (overlapping autofluorescence and
immunofluorescence shown in orange). The autofluorescent
storage material (arrows) was almost completely restricted to
cells that did not have the stellate GFAP-positive processes
typical of astrocytes
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preparations may indicate that a cell type in which the
16 kDa proteins accumulate are selectively lost as the
disease progresses.
Vacuolar V0 and mitochondrial F0 ATPase subunit
c have been previously reported to be associated with
NCL sheep pancreas storage bodies (Fearnley et al
1990; Palmer et al 1986, 1997). Bands of approximately
the same molecular weight as mitochondrial F0
ATPase subunit c were detected in silver-stained gels
of the extracts of storage bodies from NCL sheep brain
and pancreas (Fig. 4B). However, neither vacuolar V0
nor mitochondrial F0 ATPase subunit c was detected
in the storage body preparations from Tibetan terrier
cerebral cortex. This is in contrast to a previous report
that vacuolar V0 ATPase subunit c could be demon-
strated by western blotting in extracts from livers of
Tibetan terriers with NCL (Palmer et al 1997). This
suggests that V0 ATPase subunit c may be present in
the storage bodies from some tissues but not others in
the same animal. However, in the study by Palmer and
colleagues (Palmer et al 1997) it was also reported that
western blotting demonstrated the presence of vacuo-
lar V0 ATPase subunit c in storage bodies from the
pancreas of sheep with NCL. We analysed storage
bodies from sheep pancreas provided by the same
laboratory and did not detect vacuolar V0 ATPase
subunit c in this preparation. Extracts of the sheep
pancreas storage bodies did contain a component with
the same apparent molecular weight as vacuolar V0
ATPase subunit c (16 kDa), but mass spectral analysis
of this band only definitively identified histone H4 and
mitochondrial F0 ATP synthase subunit c. The V0
ATPase may also have been present in this band, as
suggested by the findings of Palmer and colleagues,
but if so, its relative abundance was too low for us to
confidently identify it by tandem MS analysis. The
presence of mitochondrial F0 ATP synthase subunit c
in the 16 kDa band is not surprising as this 7.6 kDa
protein tends to form oligomers (Fearnley et al 1990).
Of the NCLs where storage body protein composi-
tions have been analysed, the specific accumulation of
GFAP in brain storage bodies may be unique to the
Tibetan terrier disorder, although the presence of this
protein in storage bodies from other NCLs cannot be
ruled out on the evidence currently available. In
previous studies on storage bodies isolated from
animals and humans with NCL, bands were present
on gels that could correspond to GFAP, but attempts
were not made to identify the proteins in these bands
(Fearnley et al 1990; Hall et al 1991). The fact that the
Tibetan terrier storage bodies are enriched in predom-
inantly a single or a few proteins suggests that the
mechanism underlying storage body accumulation in
these dogs has some features in common with the
other NCLs. On the other hand, the distinct identity of
the major accumulating proteins suggests that the
genetic defect in the Tibetan terriers differs from
those in the other forms of NCL. Indeed, candidate
gene analyses and homozygosity mapping have exclud-
ed mutations in most of the known NCL genes as the
basis for the Tibetan terrier disease, including some
recently identified late-onset disorders in animals
(Dro¨gemu¨ller et al 2005; Wo¨hlke et al 2005, 2006;
Johnson et al unpublished data).
The specific accumulation of GFAP in Tibetan
terrier NCL suggests that normal turnover of this
protein may require a specific enzyme or interacting
protein whose absence cannot be completely compen-
sated for by alternative pathways for protein degrada-
tion. The pathways via which GFAP is normally
degraded in cells have not been completely elucidated.
GFAP undergoes a number of posttranslational
modifications, including glycosylation, citrullination
and phosphorylation, that could affect its turnover
(Ishigami et al 2005; Korolainen et al 2005). It has been
demonstrated that elimination of phosphorylation
sites in GFAP enhances degradation of this protein
(Takemura et al 2002). It is therefore possible that the
accumulation of GFAP in the Tibetan terrier disease
results from a defect in posttranslational modification
of the protein or in recognition of a specific modified
form of GFAP by the protein degradative machinery
of the cell. It has been hypothesized that oxidative
damage is involved in the pathology of at least some
forms of NCL (Siakotos et al 1995), and there is
evidence that GFAP is specifically subject to autox-
idative modification in Pick disease, another neurode-
generative disorder (Muntane et al 2006). Similar
oxidative damage could be involved in the accumula-
tion of GFAP in Tibetan terrier NCL. However, the
proteins that accumulate in most other NCLs do not
appear to have abnormal posttranslational modifica-
tions such as those characterized by oxidative damage.
GFAP accumulation may also result from alterations
in its interactions with other cytoskeletal proteins
(Tian et al 2006).
Abnormal intracellular accumulation of GFAP
occurs in another neurodegenerative disorder called
Alexander disease (Hsiao et al 2005; Li et al 2005).
This disease results from mutations in GFAP, with
variations in the age of onset and severity depending
on the specific underlying mutation (Asahina et al
2006; Hsiao et al 2005; Johnson 2004; Li et al 2005).
Alexander disease differs in significant respects from
Tibetan terrier NCL. In Alexander disease, GFAP
accumulation occurs in cytoplasmic aggregates called
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Rosenthal fibres that differ morphologically from NCL
storage bodies (Hsiao et al 2005; Li et al 2005). The
accumulation is restricted to astrocytes in Alexander
disease (Hsiao et al 2005), unlike in NCL where
storage body accumulation occurs in both neurons
and glia (Katz et al 2005b). In the Tibetan terrier
disease, little if any of the storage body accumulation
occurs in cells that have morphologies typical of
astrocytes (Fig. 6). In addition, Alexander disease is
inherited in a dominant fashion (Li et al 2005), whereas
Tibetan terrier NCL is clearly a recessively inherited
disorder (Katz et al 2005b; Riis et al 1992). We have
recently identified affected Tibetan terriers that are
heterozygous for single nucleotide polymorphism
(SNP) markers immediately adjacent to GFAP (un-
published data); this confirms that mutations in or near
GFAP are not responsible for this recessive disorder.
GFAP accumulation outside of astrocytes has also
been reported in brains of Alzheimer disease and
Down syndrome patients (Hol et al 2003). In affected
subjects with no apparent GFAP gene mutations,
GFAP expression, including several novel splice var-
iants, was found in hippocampal neurons. This obser-
vation, along with the current findings, suggest that
aberrant GFAP expression and accumulation may be
secondary to neurodegenerative changes in general
rather then being linked closely to the primary defect
underlying a specific neurodegenerative disorder.
Two splice variants of GFAP have been reported in
dogs: isoforms 1 and 2 (GenBank accession numbers
XP 537614 and XP 848378 respectively). These two
forms differ only from amino acid residue 392 to the
carboxyl terminus (residue 432 in isoform 1 and 433 in
isoform 2). Based on the mass spectral analysis, it
appears that only isoform 2 is present in the storage
bodies. A number of GFAP splice variants have also
been reported in humans and other species (Condorelli
et al 1999; Nielsen et al 2002; Singh et al 2003). Canine
isoform 2 corresponds to the isoform that is normally
expressed predominantly in humans (Fuchs and Weber
1994; Reeves et al 1989). Therefore, it is unlikely that
Tibetan terrier NCL results from an abnormality in
GFAP mRNA splicing or excessive production of a
minor isoform.
Whatever the mechanism underlying specific accu-
mulation of GFAP in lysosomal storage bodies,
discovery of the association of this protein with the
storage bodies in the canine disorder may lead to
better characterization of some forms of human and
animal NCLs for which the genetic basis has not yet
been determined. In the Tibetan terrier disease, the
onset of clinical symptoms occurs relatively late in life.
A number of cases of adult-onset NCL have been
reported in humans (Martin 1991). These disorders are
usually referred to as Kufs disease but, based on the
heterogeneity in clinical signs, they probably represent
a group of genetically diverse disorders. The storage
material composition in most Kufs disease patients and
in other late-onset NCLs has not been characterized,
nor have the mutations responsible for these disorders
been identified. Because of similarities in disease
phenotypes between some of the human adult-onset
NCLs and the Tibetan terrier disease, it would be of
interest to determine whether any of the human cases
are also characterized by specific GFAP accumulation.
Accumulation of the same protein in the storage
bodies would suggest that the human and canine
diseases may result from mutations in orthologous
genes. If this proves to be the case, the Tibetan terrier
could serve as a useful model for some forms of adult-
onset NCL in humans.
Identification of histone H4 in storage bodies from
both Tibetan terrier brain and sheep pancreas suggests
that storage of this protein in at least some cell types
may be a common feature of the NCLs. However, this
protein was not detected in the sheep brain storage
body preparation. On the other hand, ubiquitin and
prosaposin were detected in sheep brain storage bodies
but not in the storage bodies from sheep pancreas or
Tibetan terrier brain. Differences in storage protein
composition between different tissues of the same
animal and between animals with different forms of
NCL mirror differences in ultrastructural appearances
of the storage bodies. All of the NCLs appear to be
characterized by selective accumulation of small
numbers of specific proteins. Differences in which
proteins accumulate in the different forms of NCL and
in different tissues may provide important clues to the
mechanisms underlying disease pathology and help to
explain why certain cell types degenerate in the NCLs
whereas other cell types that accumulate storage
material appear to survive unimpaired. Therefore, it
will be important to further study differences in
storage body protein composition in different tissues,
in different forms of NCL, and at different disease
stages for each form of NCL.
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